TLSA Tiziana Life Sciences Ltd. Total Asset Value of Company
The price action for Tiziana Life Sciences (TLSA) on the GURU.Markets platform, where total assets amount to 14.13, indicates a business whose prospects depend on the success of immunotherapy for neurodegenerative pathologies, patents, and investments. Tiziana Life Sciences provides complex temperature-controlled antibody transport, minimizing customs risks. Meanwhile, capital is entirely absorbed by clinical trial costs, which temporarily precludes margin growth.
Analytical breakdowns and data insights for company Tiziana Life Sciences PLC (TLSA)
- market value and analyst target forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Tiziana Life Sciences|TLSA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Tiziana Life Sciences, Ltd.|TLSA - Company Aggregate Debts|Debts to Book Capitalization Tiziana Life Sciences, Ltd.|TLSA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Tiziana Life Sciences|Interim Coverage Ratio tizianalifesciences.com
- net income and valuation multiples indicators:
Fundamental valuation:Tiziana Life Sciences
Total assets determine the aggregate value of a company's resources, combining equity and liabilities to assess the scale of the business. By analyzing the trajectory of all corporate resources, an investor can perform a reverse calculation via ROA, which reveals the extent to which balance sheet growth depends on the quality of collateral coverage. This metric allows for the tracking of the risk of inflated liabilities in the absence of real security. For Tiziana Life Sciences (TLSA), this indicator reflects the financing efficiency of costly clinical trials for neurodegenerative drugs.
Key competitors
argenx.com (ARGX) - Company Total Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|SVRA: Cumulative Company Assets|Rigel Corp - Aggregate Business Assets|ANAB: Company Total Assets|ATXS - Company Total Asset Base|Cumulative Company Assets ENGN|RAPT Therapeutics Inc. - Total Asset Value of Company|Company Total Assets JBIO|Company Total Asset Base Aclaris Therapeutics, Inc|Company Total Assets KYTX (Kyverna Therapeutics)|Company Total Assets cabalettabio.com CABA|VTYX - Aggregate Company Assets|THTX (Theratechnologies, Inc.) - Total Business Assets|AVTX: Company Total Assets|Eledon Pharmaceuticals, Inc (ELDN) - Company Total Assets|Cumulative Company Assets AGEN|CLYM: Aggregate Asset Value|Aggregate Company Assets Zura Bio (ZURA)|Aggregate Company Assets ATYR (aTyr Pharma Inc)|Company Total Assets ADAG (Adagene Inc.)|Company Total Asset Base ImageneBio (IMA)|Shattuck Therapeutics - Company Total Assets|Total Asset Value of Company EQ|CNTB: Company Total Assets|Company Assets Immunic (IMUX)|Cumulative Company Assets ATRA|IFRX: Aggregate Asset Value|Aggregate Company Assets X4 Pharmaceuticals (XFOR)|Company Total Asset Base adicetbio.com|Company Total Assets CELU (Celularity)|INMB - Cumulative Company Assets|Barinthus Bio - Company Total Assets|Company Total Asset Base Kezar Life Sciences Inc KZR|SABS: Company Total Assets|Company Assets akaritx.com (AKTX)|Aggregate Company Assets Enlivex Therapeutics Ltd|Total Business Assets QTTB (Q32 Bio Corp)|Company Total Assets GOVX|Cumulative Company Assets Edesa Biotech Corp EDSA|Company Total Assets IBIO (iBio, Inc.)|Carisma Therapeutics Inc (CARM) - Company Assets|XTLB - Aggregate Company Assets|Company Total Asset Base Bolt Biotherapeutics BOLT|HCWB (hcwbiologics.com) - Cumulative Company Assets|APVO: Aggregate Business Assets|Aggregate Company Assets AIM ImmunoTech Inc.|Aggregate Company Assets ADTX|Aggregate Company Assets GRI Bio (GRI)|Company Total Asset Base XORTX Therapeutics Inc|Company Total Assets HIND (ReShape Lifesciences)|Company Total Assets Revelation Biosciences Corp REVB|INDP - Aggregate Company Assets|Total Asset Value of Company SCNI|CALI: Company Total Assets|Affimed N.V. - Aggregate Asset Value|ALLK (Allakos Inc) - Company Total Assets|Company Total Assets HOOKIPA|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|ITOS (iteostherapeutics.com) - Aggregate Asset Value|Aggregate Company Assets Ocean Biomedical OCEA|TCBP - Cumulative Company Assets|Third Harmonic Bio, Inc - Company Total Assets